vTv Therapeutics Inc.
VTVT
$33.28
$0.491.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -2.32% | 129.73% | |||
| Gross Profit | -131.48% | 812.92% | |||
| SG&A Expenses | 12.22% | 15.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.61% | 72.18% | |||
| Operating Income | -159.88% | 395.03% | |||
| Income Before Tax | -154.09% | 438.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -154.09% | 438.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -154.09% | 438.11% | |||
| EBIT | -159.88% | 395.03% | |||
| EBITDA | -159.87% | 395.12% | |||
| EPS Basic | -154.09% | 438.11% | |||
| Normalized Basic EPS | -154.09% | 438.11% | |||
| EPS Diluted | -163.76% | 386.86% | |||
| Normalized Diluted EPS | -163.79% | 386.70% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -15.20% | 17.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||